DarioHealth Corp
NASDAQ:DRIO
| Market Cap (Intraday) | 105.30M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.18 |
| 50-Day MA | $5.03 |
| 200-Day MA | $5.04 |
DarioHealth Corp Stock, NASDAQ:DRIO
18 West 18th Street, 5th floor, New York, New York 10011
United States of America
Phone: +1.833.914.3796
Number of Employees: 241
Description
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in New York, NY.